Direct Answer
IQVIA reports revenue across 3 business segments in its fiscal 2025 Form 10-K. Research and Development Solutions is the largest, with $8.9 billion of revenue (55% of the total), followed by Technology and Analytics Solutions at $6.6 billion (41%).
How Does IQVIA Make Money?
No single line supplies a majority of revenue: the largest, Research and Development Solutions, is 55%, which spreads IQVIA's exposure across several demand drivers. Between fiscal 2024 and 2025, Contract Sales and Medical Solutions grew fastest (+9.7%) and Research and Development Solutions slowest (+4.3%), so the revenue mix tilts toward Contract Sales and Medical Solutions while that gap lasts.
| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Research and Development Solutions | $8.9 billion | $8.5 billion | 54.5% | 4.3% |
| Technology and Analytics Solutions | $6.6 billion | $6.2 billion | 40.6% | 7.6% |
| Contract Sales and Medical Solutions | $788 million | $718 million | 4.8% | 9.7% |
Where Does IQVIA's Revenue Come From?
Regions follow the definitions in the filing; most companies assign revenue by customer location.
| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Americas | $7.7 billion | $7.4 billion | 47.5% | 5.3% |
| EMEA | $5.2 billion | $4.9 billion | 31.8% | 5.4% |
| Asia Pacific | $3.4 billion | $3.1 billion | 20.7% | 8.0% |
What the Segment Figures Do Not Show
The rows above add up to 100% of IQVIA's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.
Where These Numbers Come From
Every figure on this page is a value IQVIA reported in the segment note and revenue disclosures of its Form 10-K filed February 17, 2026 (accession 0001628280-26-008322), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.
Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.
Frequently Asked Questions
What are IQVIA's business segments?
In its fiscal 2025 Form 10-K, IQVIA reports revenue for Research and Development Solutions, Technology and Analytics Solutions and Contract Sales and Medical Solutions.
Which part of IQVIA brings in the most revenue?
Research and Development Solutions, with $8.9 billion of revenue in fiscal 2025, or 55% of the total.
Where does IQVIA report its segment results?
In the segment note to the financial statements in its Form 10-K, most recently filed February 17, 2026, alongside management's discussion of each segment's results.